Work

Phase 1 Trial of CRISPR-Cas9 Gene Editing Targeting ANGPTL3

Year: 2025

Type: article

Study design: Clinical Trial

Source: New England Journal of Medicine

DOI: 10.1056/nejmoa2511778

Authors: Luke J. Laffin, Stephen J. Nicholls, Russell S. Scott, Peter M. Clifton, John Baker, Ashish Sarraju, Shweta Singh, Qiuqing Wang, Kathy Wolski, Huansheng Xu, Jen Nielsen, Naimish Patel, Jason M. Duran, Steven E. Nissen

Institutions: Cleveland Clinic, Monash University, New Zealand Clinical Research, Royal Adelaide Hospital

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4416039232

FWCI: 61.66

Cites: 19

Cited by: 71

Related to: